BWA
MIRM icon

Basecamp Wealth Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Basecamp Wealth Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Sell
10
-49
-83% -$4.92K ﹤0.01% 1483
2026
Q1 		$5.45K Hold
59
– – ﹤0.01% 1166
2025
Q4 		$4.66K Buy
+59
New +$4.24K ﹤0.01% 1160

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Basecamp Wealth Advisors's MIRM Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 83% in Q2 2026, selling an estimated $4.92K and leaving 10 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Basecamp Wealth Advisors first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.45K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Basecamp Wealth Advisors held 10 shares of Mirum Pharmaceuticals worth $1.17K as of Q2 2026.
  • Basecamp Wealth Advisors sold 49 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.92K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1483 holding.
  • Basecamp Wealth Advisors first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Mirum Pharmaceuticals position peaked at $5.45K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.